Miles, D., Baselga, J., Amadori, D., Sunpaweravong, P., Semiglazov, V., Knott, A., . . . Swain, S. M. (2013). Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: Subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). Springer US.

Miles, David, José Baselga, Dino Amadori, Patrapim Sunpaweravong, Vladimir Semiglazov, Adam Knott, Emma Clark, Graham Ross, et Sandra M. Swain. Treatment of Older Patients With HER2-positive Metastatic Breast Cancer With Pertuzumab, Trastuzumab, and Docetaxel: Subgroup Analyses From a Randomized, Double-blind, Placebo-controlled Phase III Trial (CLEOPATRA). Springer US, 2013.

Miles, David, et al. Treatment of Older Patients With HER2-positive Metastatic Breast Cancer With Pertuzumab, Trastuzumab, and Docetaxel: Subgroup Analyses From a Randomized, Double-blind, Placebo-controlled Phase III Trial (CLEOPATRA). Springer US, 2013.